NS
VIRX

NBC Securities’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

NBC Securities’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,400
Closed -$1K – 2226
2024
Q1 		$1K Buy
+1,400
New +$1.02K ﹤0.01% 2165
2023
Q4 		– Sell
-700
Closed – – 2247
2023
Q3 		$0 Buy
+700
New +$950 ﹤0.01% 2186

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NBC Securities's VIRX Position: Q2 2024 in Review

NBC Securities sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2024, closing a stake of 1,400 shares — an estimated $1K sold.

NBC Securities first reported a position in VIRX in Q3 2023 and held it in 2 quarters. The position peaked at $1K in Q1 2024. 40 funds tracked by Wall St. Rank hold VIRX as of Q2 2024.

  • NBC Securities reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • NBC Securities sold 1,400 Viracta Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1K.
  • NBC Securities first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • NBC Securities's Viracta Therapeutics, Inc. Common Stock position peaked at $1K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2024.

Based on NBC Securities's 13F filing for Q2 2024, filed 10 Jul 2024.